STAT+: OpenAI can’t have it both ways on GPT-5 and health
Why OpenAI may run into trouble with the FDA for promoting GPT-5's health advice with little supporting evidence
Previous Post
FriskaAi Integrates with Dexcom’s CGM Data for AI-Powered Diabetes Management
Next Post
The biotech bi-weekly: preserving biodiversity, engineering phage therapies, manufacturing difficult-to-express molecules and revolutionizing viticulture
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago